Progyny Inc (PGNY)

Pretax margin

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Earnings before tax but after interest (EBT) US$ in thousands 83,202 70,691 24,441 32,435 8,679
Revenue US$ in thousands 1,165,810 1,091,910 787,727 501,082 344,979
Pretax margin 7.14% 6.47% 3.10% 6.47% 2.52%

December 31, 2024 calculation

Pretax margin = EBT ÷ Revenue
= $83,202K ÷ $1,165,810K
= 7.14%

To analyze Progyny Inc's pretax margin over the years from December 31, 2020, to December 31, 2024, we observe the following trend:

1. In December 2020, Progyny Inc's pretax margin stood at 2.52%, indicating that for every dollar of revenue, the company retained 2.52 cents before accounting for taxes.

2. By December 2021, the pretax margin improved significantly to 6.47%, reflecting enhanced operational efficiency or cost management strategies. This suggests that the company was able to generate higher earnings relative to its revenue.

3. In December 2022, the pretax margin dropped to 3.10%, indicating a decrease in profitability compared to the previous year. This decline could be attributed to various factors such as increased expenses or lower revenue generation.

4. By December 2023, the pretax margin rebounded to 6.47%, matching the level seen in 2021. This recovery suggests that Progyny Inc may have implemented corrective measures to enhance profitability and financial performance.

5. Finally, as of December 2024, the pretax margin further improved to 7.14%, reaching a new high during the period under review. This rise may indicate sustained efforts in optimizing operations and maximizing profitability.

In conclusion, Progyny Inc's pretax margin demonstrated fluctuations over the analyzed years, with improvements observed in 2021, 2023, and 2024, while experiencing a dip in 2022. This highlights the company's ability to adapt to changing business conditions and strategically manage its finances to drive profitability.


Peer comparison

Dec 31, 2024

Company name
Symbol
Pretax margin
Progyny Inc
PGNY
7.14%
DaVita HealthCare Partners Inc
DVA
9.49%
Sotera Health Co
SHC
10.10%